483 Chartwell Pharmaceuticals Sep 2018

483 Chartwell Pharmaceuticals Sep 2018

Sony Mathews FDA$119.00 - Available Now

FDA investigators audited the Chartwell Pharmaceuticals - Congers, NY, United States facility and issued inspectional observations (via FDA 483) on 26 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Sep 2018
  • Location: Congers, United States
  • FEI: 3008897678
Add To Cart